Piracetam Market

Piracetam is suitable for acute, chronic cerebrovascular disease, brain trauma, a variety of toxic encephalopathy and other causes of memory loss and mild, moderate brain dysfunction drugs.

Piracetam Market contains market size and forecasts of Piracetam in Global, including the following market information:

Global Piracetam Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Piracetam market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Piracetam include Jiangsu Chenpai Pharmaceutical Group, Shandong Weigao Pharmaceutical, Shandong Xinhua Pharmaceutical, Guorui Pharmaceutical Group, Shanghai Modern Hazen Shangqiu Pharmaceutical, Duoduo Pharmaceutical, Shandong Fangming Pharmaceutical Group, Hangzhou Minsheng Pharmaceutical and Shandong Qidu Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Piracetam companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Piracetam Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Piracetam Market Segment Percentages, by Type, 2021 (%)

Injection

Capsule

Tablets

Global Piracetam Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Piracetam Market Segment Percentages, by Application, 2021 (%)

Cerebrovascular Disease

Traumatic Brain Injuries

Toxic Encephalopathy

Other

Global Piracetam Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Piracetam Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Piracetam revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Piracetam revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Jiangsu Chenpai Pharmaceutical Group

Shandong Weigao Pharmaceutical

Shandong Xinhua Pharmaceutical

Guorui Pharmaceutical Group

Shanghai Modern Hazen Shangqiu Pharmaceutical

Duoduo Pharmaceutical

Shandong Fangming Pharmaceutical Group

Hangzhou Minsheng Pharmaceutical

Shandong Qidu Pharmaceutical

Guangdong Litai Pharmaceutical

Chenxin Pharmaceutical

Ruiyang Pharmaceutical

Hainan Huanglong Pharmaceutical

Hainan Tongyong Kangli Pharmaceutical

China Resources Shuanghelimin Pharmaceutical Jinan

Tianjin Jinyao group Henan Lixin Pharmaceutical

Zhejiang Ruixin Pharmaceutical

Furen Pharmaceutical Group

Jiangsu Yabangshengyuan Pharmaceutical

Shandong Xinyi Pharmaceutical

Shanghai Shangyao Xinyi Pharmaceutical

Shanghai Huayuan Anhui Renji Pharmaceutical

Shanghai Pukang Pharmaceutical

Northeast Pharmaceutical Group Renhetang Pharmaceutical

Huazhong Pharmaceutical

Nanjing baijingyu Pharmaceutical

Hefei Jiulian Pharmaceutical

Yichang Renfu Pharmaceutical

Guangdong Sancai Shiqi District Pharmaceutical

Guangdong South Ch

Guangdong Bangmin Pharmaceutical

Kaifeng Pharmaceutical Group

Jiangsu Shenhua Pharmaceutical

Jiangsu Pengyao Pharmaceutical

Hunan Dinuo Pharmaceutical

Shijiazhuang No. 4 Pharmaceutical

Chengdu Tongde Pharmaceutical

Shanxi Bailu Pharmaceutical

Jiangxi Qingchun Kangyuan Pharmaceutical

Liaoning Tianlong Pharmaceutical

Liaoyuan Yulong Yadong Pharmaceutical

Changchun Changqing Pharmaceutical Group